Since c-KIT mutation expression in ACC can range anywhere from 78% to 100%, there has recently been an increasing intrigue in determining the efficacy of c-KIT inhibitors in treatment of ACC [12]. The gene discussed is KIT; the disease is adrenal cortex carcinoma.